Intellia Therapeutics and ReCode Therapeutics are joining forces to develop new genomic medicines for people with cystic…
Articles by Marisa Wexler, MS
The frequent use of aminoglycosides — a class of antibiotics commonly used to help treat lung infections in people with…
A new triple-combination CFTR modulator therapy for cystic fibrosis (CF) — vanzacaftor, tezacaftor and deutivacaftor —…
Enterprise Therapeutics has raised £26 million (nearly $33 million USD) in series B financing, which the company is planning…
Treatment with SPI-1005 in adults with cystic fibrosis (CF) appeared to lessen the risk of ear damage related…
The eighth annual BreatheCon, a virtual event hosted by the Cystic Fibrosis Foundation that brings together adults with…
Results of three global clinical trials of a new triple-combination CFTR modulator therapy for cystic fibrosis (CF) — vanzacaftor,…
Treatment with the inhaled antibiotic aztreonam can stabilize lung function in people with cystic fibrosis (CF) who have…
People with cystic fibrosis (CF) who have chronic inflammation in the nose are less likely to need sinus surgery…
Inflammatory molecules that serve as markers of infection or other problems can be measured in the nasal fluid of babies…